• Curious whether BrightSpring Health Services at US$52.74 is offering value or just riding hype? This article walks you through what the current price could mean for you as an investor.
• The stock has returned 9.5% over the past week, 21.2% over the last 30 days, 37.3% year to date and 128.9% over the past year. This naturally raises questions about how much of the story is already reflected in the price.
• Recent attention around BrightSpring Health Services has centered on its position in the healthcare sector and how investors are assessing its long term growth potential. News coverage has also focused on market interest following its trading performance, which can influence how investors think about both risk and reward at current levels.
• Right now, BrightSpring Health Services has a valuation score of 2/6. The rest of this article will walk through the standard valuation checks before finishing with a more complete way of thinking about what that score could mean for you.

BrightSpring Health Services scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: BrightSpring Health Services Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company could be worth today by projecting its future cash flows and discounting them back to the present.

For BrightSpring Health Services, the latest twelve month Free Cash Flow is about $407.9 million. Analysts and extrapolated estimates used in the 2 Stage Free Cash Flow to Equity model point to projected Free Cash Flow of $1,009.7 million in 2030, with interim forecasts such as $414.2 million in 2026 and $622.7 million in 2028, all expressed in dollar terms.

Putting all of these projected and discounted cash flows together, the model arrives at an estimated intrinsic value of about $144.75 per share. Compared with the current share price of $52.74, this implies a discount of roughly 63.6%, indicating that the stock is assessed as materially undervalued on this DCF view.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests BrightSpring Health Services is undervalued by 63.6%. Track this in your watchlist or portfolio, or discover 44 more high quality undervalued stocks.

Approach 2: BrightSpring Health Services Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about what you are paying for each dollar of current earnings. It links the stock price directly to earnings, which many investors focus on when comparing opportunities across the market.

What counts as a “normal” P/E depends on how investors view the company’s growth prospects and risk. Higher expected growth or lower perceived risk can justify a higher multiple, while lower growth or higher risk usually point to a lower, more cautious P/E.

BrightSpring Health Services currently trades on a P/E of 63.41x. That is above the Healthcare sector average of 22.38x and a peer average of 20.24x. Simply Wall St’s Fair Ratio framework estimates a P/E of 34.75x for this stock, based on factors such as earnings growth, profit margins, industry, market cap and key risks. This Fair Ratio is designed to be more tailored than simple peer or sector comparisons because it adjusts for those company specific characteristics rather than using broad group averages.

Comparing the Fair Ratio of 34.75x with the current P/E of 63.41x suggests the stock is trading at a richer level than this model would indicate.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your BrightSpring Health Services Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives bring this to life by letting you set out your story for BrightSpring Health Services, link that story to concrete forecasts for revenue, earnings and margins, and see the fair value that falls out of those assumptions. All of this happens within Simply Wall St's Community page where Narratives are updated automatically as new news or earnings arrive. This allows you to compare your own fair value to the current share price when thinking about buying or selling, and to see how different perspectives can coexist. For example, one investor may align with a more optimistic view that points to a Fair Value around US$59.97, while another may lean toward a cautious view closer to US$45.23, with both grounded in clearly spelled out expectations rather than just the latest P/E screen.

For BrightSpring Health Services, we will make it really easy for you with previews of two leading BrightSpring Health Services Narratives:

Fair value in this bull case narrative: US$59.60

Implied discount to this fair value at US$52.74: about 11.5%

Revenue growth assumption: 14.66%

• Analysts in this camp focus on specialty pharmacy, rare disease drugs and home based services as key supports for revenue and margin expansion.
• They see demographic trends and integrated service offerings as important drivers for long term growth in earnings and cash flows.
• This view still flags risks around labor costs, regulation, leverage and technology adoption, which could affect how much of the upside is realized.

Fair value in this bear case narrative: US$45.23

Implied premium to this fair value at US$52.74: about 16.6%

Revenue growth assumption: 13.19%

• The bearish narrative leans on concerns around wage inflation, staffing shortages and exposure to government reimbursement shaping future margins.
• It highlights the execution risk that comes with ongoing acquisitions and integrations, as well as potential pressure from value based payment models.
• This view still acknowledges demand growth, efficiency efforts and specialty pharmacy as possible supports, but treats them as insufficient to offset the identified risks at higher prices.

Taken together, these narratives frame a range of fair values from about US$45 to nearly US$60 around the current price of US$52.74. You can use this range as a reference point when weighing your own expectations for growth, margins and risk.

To see how these results tie into long term growth, risks and valuation, check out the full range of To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for BrightSpring Health Services on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Do you think there's more to the story for BrightSpring Health Services? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.